Find, compare & contact
Metoclopramide API Manufacturers & Suppliers

Looking for Metoclopramide API 364-62-5?

Description:

Here you will find a list of producers, manufacturers and distributors of Metoclopramide. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Metoclopramide 

Synonyms:

Elieten , Metoclopramida , Metoclopramidum , Reliveran , Metoclopramide Hydrochloride  

Cas Number:

364-62-5 

DrugBank number:

DB01233 

Unique Ingredient Identifier:

L4YEB44I46

Metoclopramide is a type of Dopamine antagonists

Dopamine antagonists belong to the pharmaceutical API subcategory that plays a crucial role in the management of various medical conditions. These compounds act by blocking dopamine receptors, which are responsible for transmitting signals in the brain. By inhibiting dopamine activity, dopamine antagonists exhibit diverse therapeutic effects.

One significant application of dopamine antagonists is in the treatment of psychiatric disorders. They are commonly used to manage schizophrenia, a severe mental disorder characterized by hallucinations, delusions, and disorganized thinking. Dopamine antagonists help reduce the symptoms of schizophrenia by normalizing the excessive dopamine activity in the brain.

Additionally, these pharmaceutical APIs find application in managing other conditions such as bipolar disorder, nausea, vomiting, and certain movement disorders. Dopamine antagonists can effectively alleviate the symptoms associated with these conditions by modulating dopamine levels and restoring the balance in neural signaling.

Pharmaceutical companies utilize advanced synthesis and purification techniques to produce high-quality dopamine antagonists for use as active ingredients in various medications. These APIs undergo stringent quality control measures to ensure their safety, efficacy, and compliance with regulatory standards.

In conclusion, dopamine antagonists constitute an important subcategory of pharmaceutical APIs, offering valuable therapeutic benefits for psychiatric disorders, nausea, vomiting, and movement disorders. Their ability to selectively block dopamine receptors makes them indispensable in modern medicine, enabling improved patient outcomes and quality of life.

Metoclopramide (Dopamine antagonists), classified under Central Nervous System Agents

Central Nervous System (CNS) Agents are a crucial category of pharmaceutical Active Pharmaceutical Ingredients (APIs) that specifically target the central nervous system. The CNS encompasses the brain and spinal cord, playing a vital role in regulating and controlling various bodily functions, including cognition, movement, emotions, and sensory perception. These agents are designed to interact with specific receptors, enzymes, or ion channels within the CNS to modulate neural activity and restore normal functioning.

CNS agents comprise a diverse range of pharmaceutical APIs, including analgesics, anesthetics, antipsychotics, sedatives, hypnotics, anti-epileptics, and antidepressants. Each subcategory addresses distinct neurological disorders and conditions. For instance, analgesics alleviate pain by targeting receptors in the brain and spinal cord, while antipsychotics are employed to manage psychosis symptoms in mental illnesses such as schizophrenia.

The development of CNS agents involves rigorous research, molecular modeling, and extensive clinical trials to ensure safety, efficacy, and specific target engagement. Pharmaceutical companies invest significant resources in identifying novel drug targets, synthesizing new compounds, and optimizing their pharmacological properties. These agents undergo rigorous regulatory evaluations and must adhere to stringent quality standards and guidelines.

Given the prevalence of CNS disorders globally, the market demand for effective CNS agents is substantial. The development of innovative CNS APIs not only improves patient outcomes but also provides valuable commercial opportunities for pharmaceutical companies. Continued advancements in CNS agent research and development hold the promise of groundbreaking therapies that can improve the quality of life for individuals affected by neurological conditions.

• Senova Technology Co., Ltd. from China, product country of origin China
• Shandong Chenghui Shuangda Pharmaceutical Co. Ltd. from China, product country of origin China
• Aurora Industry Co., Ltd from China, product country of origin China
• SETV Global from India, product country of origin India
• Hari Ganesh Pharma Private Limited from India, product country of origin India
• TIEFENBACHER API + Ingredients from Germany, product country of origin Unknown
• Cosma from Italy, product country of origin Italy
• Anphar Labs. from India, product country of origin India
• Finorga from France, product country of origin France
• Amsa S.P.A. from Italy, product country of origin Italy
• Lundbeck Pharma from Italy, product country of origin Italy
• Ipca Labs. from India, product country of origin India
• Emcure Pharma from India, product country of origin India
• ICROM from Italy, product country of origin Italy

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.